Stephen Schuster
MD
Professor of Medicine; Director, Lymphoma Program
👥Biography 个人简介
Stephen Schuster co-led the JULIET trial establishing tisagenlecleucel as an effective CAR-T therapy for relapsed/refractory DLBCL, building on the foundational work at Penn on adoptive cell therapy. He has subsequently investigated epcoritamab (anti-CD3xCD20 bispecific) in relapsed DLBCL and studied sequencing of CAR-T and bispecific therapies. His research also addresses the immune biology of DLBCL tumor microenvironment and how it influences CAR-T engraftment and persistence. He remains active in developing novel lymphoma clinical trials at Penn.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Stephen Schuster 的研究动态
Follow Stephen Schuster's research updates
留下邮箱，当我们发布与 Stephen Schuster（University of Pennsylvania, Abramson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment